Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Actavis_plc
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:founded |
1948
|
| gptkbp:founder |
gptkb:Gavin_S._Herbert
|
| gptkbp:headquartersLocation |
Irvine, California, United States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Allergan, Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:David_E._I._Pyott
|
| gptkbp:notableProduct |
gptkb:Botox
gptkb:Juvederm gptkb:Restasis gptkb:Lumigan gptkb:Natrelle |
| gptkbp:numberOfEmployees |
11,400 (2014)
|
| gptkbp:parentCompany |
gptkb:Allergan_plc
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:specialty |
neurology
dermatology gastroenterology eye care medical aesthetics |
| gptkbp:stockSymbol |
gptkb:AGN
|
| gptkbp:successor |
gptkb:Allergan_plc
|
| gptkbp:tradedOn |
gptkb:New_York_Stock_Exchange
|
| gptkbp:website |
www.allergan.com
|
| gptkbp:bfsParent |
gptkb:Allergan
gptkb:Actavis_Generics |
| gptkbp:bfsLayer |
6
|